logo-loader
ASX:THC

THC Global Group Ltd

Receive alerts
Market:
ASX
Market Cap:
$59.33 m
Price
$0.44
Change
-1.14%
52 weeks high
0.66
52 weeks low
0.41

Filter by article type

Viewing results 1-25 of 103

Health

THC Global secures 24.6-hectare medical cannabis cultivation site to increase production

This is a major step in being able to deliver Australian produced medicinal cannabis products to Australian patients at commercial scale into early 2020....

2 weeks, 3 days ago
Health

THC Global Group Queensland cannabis production facility opened by Australian Health Minister Greg Hunt

The Southport production facility is the largest bio-floral pharma extraction facility in the Southern Hemisphere....

3 weeks, 3 days ago
Health

THC Global Group’s second manufacturing licence opens door to product development

This follows the manufacturing licence granted in June 2019 for its Bundaberg facility. ...

on 9/7/19
Health

THC Global Group Ltd granted trading halt by ASX

THC Global operates under a ‘Farm to Pharma’ pharmaceutical model....

on 5/7/19
Health

THC Global has full suite of cannabis licences to advance farm-to-pharma model

In addition to its core Australian medicinal cannabis assets, THC has a significant Canadian presence – both in cannabis and in hydroponics equipment....

on 26/6/19
Health

THC Global's new manufacturing licence a boost for cannabis honey products

Eve Investments, via agreements with THC Global, now has a viable option to access THC’s cannabis licensing for research and development of its products....

on 17/6/19
Health

THC Global granted cannabis Manufacture Licence, shares surge 20%

Receipt of the third and final cannabis licence underlines the company’s position as a leader in the medicinal cannabis sector in Australia....

on 13/6/19
Health

THC Global has news pending on grant of a Manufacture Licence by Office of Drug Control

The company has been granted a trading halt which will remain in place until the start of trading on June 14 or when an announcement is released to the market....

on 12/6/19
Health

THC Global Group focuses on building a global cannabis company

The company has a clear path towards leading the Australian cannabis market to produce high-grade pharmaceutical medical cannabis products. ...

on 28/5/19
Health

THC Global shares rise after securing medicinal cannabis export licence

The company is also expanding the total leased land for its Northern NSW cannabis cultivation site up to 150,000 square metres....

on 15/5/19
Health

THC Global raises nearly $3 million to fund transition into full-scale medicinal cannabis production

The company is waiting final licencing and permitting approvals to begin manufacturing at its Canndeo site in Canada....

on 7/5/19
Health

THC Global Group progresses core drivers of revenue growth

THC is executing a medicinal cannabis strategy in Australia, New Zealand and Canada and is looking to Asian markets....

on 24/4/19
Health

THC Global directors and CEO to participate in SPP

Shares in the company are trading at 52.5 cents, a premium to the 50-cent offer price....

on 18/4/19
Health

THC Global's Canadian division boosts revenue 22% in March quarter

Having secured a substantial growing capacity over two sites and an industry-leading pharmaceuticals bio-manufacturing facility, THC Global is in a prime position to service domestic patients and the export market. ...

on 17/4/19
Health

THC Global Group opens SPP and notes near term milestones

The company expects to receive its final Australian cannabis licenses and permits in the near-term....

on 10/4/19
Health

THC Global Group launches SPP ahead of final licensing

Shareholders can acquire shares at 50 cents, being a discount to the last price of 56.5 cents....

on 8/4/19
Health

THC Global Group expands into Asia with partnership

THC has partnered with a Malaysian bio-tech firm to deliver medicinal cannabis products....

on 5/4/19
Health

THC Global acquires site in Canada for cannabis production

Stage 1 initial annual yield expected to be 37,000 kilograms dried cannabis flower with an estimated revenue of $287 million....

on 26/3/19
Health

THC Global Group shares halted ahead of acquisition details

The company deemed a trading halt necessary due to time differences with Canada....

on 25/3/19
Health

THC Global’s focus on vertical integration is beginning to show dividends: The Green Fund

The company has secured significant cultivation capacity over two grow sites and an industry-leading bio-manufacturing facility....

on 11/3/19
Health

THC Global grows 32% in 2018 after acquisitions and approvals

THC is developing its medicinal cannabis strategy in Australia, New Zealand and Canada and is looking to Asian markets....

on 5/3/19